Viral Hepatitis Grand Rounds - Home Page

ViralHep_GR_Perelman_www2012_v2.jpg  

Jointly provided by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.

 Perelman School of Medicine Small JPEG         VE logo 300px  

GrandRound_Live_Series_Schedule_button.jpg          

 

Series Overview:

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity "HIV Grand Rounds" which, in partnership with the Perelman School of Medicine at the University of Pennsylvania, is preparing for its eighth year running. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet on 2 Wednesdays each month at 12:00 pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.

Presentations cover the most important and current topics in hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.

Back to Top

Target Audience:

The program has been designed for physicians, fellows, residents, medical students, physician assistants, pharmacists, medical assistants, professional nurses, advanced pracice nurses in dermatology, family medicine, internal medicine, infectious diseases, obstetrics and gynecology, pediatrics, psychiatry and neurology.

Back to Top

Commercial Support Acknowledgement:

These activities are supported by educational grants from Gilead Sciences Medical Affairs and Merck & Co. Inc.

Back to Top

Learning Objectives for the Series:

Upon completion of the program, participants should be able to:
  • Demonstrate increased understanding of the epidemiology of and risk factors for viral hepatitis; 
  • Increase the rate of testing of viruses associated with hepatitis;  
  • Demonstrate improved knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral hepatitis;  
  • Demonstrate an improved understanding of the treatment of viral hepatitis in patients co-infected with HIV or other viral infections.

 

Course Directors:

K. Rajender Reddy MD

K. Rajender Reddy, MD

Ruimy Family President's Distinguished Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
Medical Director, Liver Transplantation

University of Pennsylvania

Philadelphia, Pennsylvania

faculty photo
 

David E. Kaplan, MD, MSc

Assistant Professor of Medicine
Division of Gastroenterology 
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

 

 Ian Frank

Ian Frank, MD

Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

 
                       
 

 Back to Top

Back to Top

Live Session Topic and Speaker:

The next presentation of Viral Hepatitis Grand Rounds from the
Perelman School of Medicine at the University of Pennsylvania:


Date: December 7, 2017

Speaker: Therese Bittermann, MD

Topic: Real Cases from the University of Pennsylvania

  Upcoming PROGRAM SCHEDULE    



 

    Hardware/Software Notice:

    You will need Internet to participate in this activity.

    Accreditation Statement:

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.

    Back to Top

    Credit Designation Statement:

    The Perelman School of Medicine at the University of Pennsylvania designates each live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Back to Top

    Disclosures:

    It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

    The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

    The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Michael Schoen, PhD and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Brian Boyle MD, Richard Gordon and Oliver Fultz), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

    Back to Top

    following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

     Brian Boyle, MD
     Rick Gordon
     Oliver Fultz
     Mila Kostic, CHCP, FACEHP
           
     

    The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

    Presenters Name Commercial Supporter Relationship

    Planning Committee Members Disclosures:

    K. Rajender Reddy, MD

    Gilead; AbbVie; Merck

    Advisory Board

     

    Merck; AbbVie; Gilead; BMS; Janssen

    Research Grants

    David Kaplan, MD

    Bayer Pharmaceuticals; Invio Pharmaceuticals

    Investigator

     

    Gilead

    Research Grants

    Ian Frank, MD

    Gilead

    Advisory Board

     

    ViiV; GSK

    Research Grants

    Back to Top

    Discussion of Investigational and/or Off-label Use of Commercial Products and Devices:

    The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

    Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

    Back to Top

    Disclaimer:

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

    Back to Top

     GrandRound_Live_Series_Schedule_button.jpg          

    You may contact Richard Gordon by phone at 1-773-368-3932 or by email at Rgordon@viraled.com for additional assistance.

    For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME: penncme@mail.med.upenn.edu.

    We look forward to bringing the highest quality, outcomes driven CME directly to you.

    Perelman School of Medicine Small JPEG                                                                    VE logo 300px

Prepare to print

Share this page:

Get link code to this page                     


Back to Top